Mead Johnson Nutrition CO Company Profile (NYSE:MJN)

About Mead Johnson Nutrition CO (NYSE:MJN)

Mead Johnson Nutrition CO logoMead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company marketed its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe, as of December 31, 2016.

Industry, Sector and Symbol:
  • Sector: Non-Cyclical Consumer Goods & Services
  • Industry: Baby Food
  • Sub-Industry: Packaged Foods & Meats
  • Symbol: NYSE:MJN
  • CUSIP: 58283910
  • Web:
Average Prices:
  • 50 Day Moving Avg: $89.62
  • 200 Day Moving Avg: $84.34
  • 52 Week Range: $69.25 - $94.40
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 26.16
  • P/E Growth: 0.00
  • Net Margins: 13.31%
  • Return on Assets: 11.35%
  • Debt-to-Equity Ratio: -7.57%
  • Current Ratio: 2.15%
  • Quick Ratio: 1.77%
  • Average Volume: 1.93 million shs.
  • Beta: 1.57
Frequently Asked Questions for Mead Johnson Nutrition CO (NYSE:MJN)

What is Mead Johnson Nutrition CO's stock symbol?

Mead Johnson Nutrition CO trades on the New York Stock Exchange (NYSE) under the ticker symbol "MJN."

How often does Mead Johnson Nutrition CO pay dividends? What is the dividend yield for Mead Johnson Nutrition CO?

Mead Johnson Nutrition CO declared a quarterly dividend on Wednesday, May 31st. Stockholders of record on Tuesday, June 20th will be paid a dividend of $0.4125 per share on Wednesday, July 5th. This represents a $1.65 annualized dividend and a dividend yield of 1.83%. The ex-dividend date is Friday, June 16th. View Mead Johnson Nutrition CO's Dividend History.

How were Mead Johnson Nutrition CO's earnings last quarter?

Mead Johnson Nutrition CO (NYSE:MJN) announced its quarterly earnings results on Thursday, April, 27th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.79 by $0.01. The business had revenue of $883.50 million for the quarter, compared to analysts' expectations of $911.63 million. Mead Johnson Nutrition CO's quarterly revenue was down 8.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.87 EPS. View Mead Johnson Nutrition CO's Earnings History.

When will Mead Johnson Nutrition CO make its next earnings announcement?

Mead Johnson Nutrition CO is scheduled to release their next quarterly earnings announcement on Thursday, July, 27th 2017. View Earnings Estimates for Mead Johnson Nutrition CO.

Where is Mead Johnson Nutrition CO's stock going? Where will Mead Johnson Nutrition CO's stock price be in 2017?

12 analysts have issued 1 year price targets for Mead Johnson Nutrition CO's shares. Their predictions range from $66.00 to $95.00. On average, they anticipate Mead Johnson Nutrition CO's stock price to reach $84.80 in the next year. View Analyst Ratings for Mead Johnson Nutrition CO.

What are analysts saying about Mead Johnson Nutrition CO stock?

Here are some recent quotes from research analysts about Mead Johnson Nutrition CO stock:

  • 1. According to Zacks Investment Research, "Mead Johnson following a dismal 2016, has made a disappointing start to the year 2017 too. The first quarter 2017 performance was poor with both the top and the bottom line numbers missing the respective Zacks Consensus Estimate. The company’s sales were quite dismal, with each of its segments posting weak numbers. In emerging markets, turmoil in Mexico and Colombia dented overall growth. Foreign currency also remained a major dampener across all regions. On a positive note, the shareholders heaved a sigh of relief with the announcement of the company’s proposed selloff to leading consumer health and hygiene company Reckitt Benckiser. We believe the merger is strategically fit for the company to overcome the on-going rough patch. The deal which represents a 29% premium to the company’s closing price before market speculation took place, should be of shareholders benefit too. At present, upside potential of the stock is limited." (4/28/2017)
  • 2. Susquehanna Bancshares Inc analysts commented, "Last week Windeln, a leading e-commerce player in German infant milk formula shipped to China (consumers buy IMF from its European website and have the product shipped to China) reported a drop in China-bound sales (bulk being IMF) of 11% in 2Q16 (after 11% growth in 1Q16, and 64% growth in 2015). New rules have generated uncertainty with consumers, with these shying away from these types of “direct imports”. We realize this in the long term could be positive for the likes of Neutral-rated MJN (as consumers buy more offline, but still seek premium imported brands), but in the near term this reflects how regulatory changes are disrupting trade in IMF in China, and in some cases forcing traders and smaller companies to clear inventories (although not the case of moms buying IMF online from Europe). Net, we remain sidelined on MJN as we think its overall business is also being affected by the uncertainty triggered by these regulatory changes. Briefbackgr ound. ( translated into English) is an e-commerce company listed in Germany (Munich HQ), delving mainly in baby and maternity related products, both of the “software” (diapers, milk formula) and “hardware” kind (strollers, baby chairs). The company is growing both organically and through acquisitions (to other parts of Europe)." (8/29/2016)

Are investors shorting Mead Johnson Nutrition CO?

Mead Johnson Nutrition CO saw a drop in short interest in the month of June. As of June 15th, there was short interest totalling 550,673 shares, a drop of 82.9% from the May 31st total of 3,221,799 shares. Based on an average daily volume of 3,698,953 shares, the short-interest ratio is currently 0.1 days. Currently, 0.3% of the shares of the company are sold short.

Who are some of Mead Johnson Nutrition CO's key competitors?

Who are Mead Johnson Nutrition CO's key executives?

Mead Johnson Nutrition CO's management team includes the folowing people:

  • Peter Kasper Jakobsen, President, Chief Executive Officer, Director
  • Michel M.G. Cup, Chief Financial Officer, Executive Vice President
  • Charles M. Urbain, Chief Operating Officer, Executive Vice President
  • Patrick M. Sheller, Senior Vice President, General Counsel, Secretary
  • James E. Shiah, Senior Vice President, Corporate Controller
  • James Jeffrey Jobe, Senior Vice President - Technical Operations
  • Ian Eric Ormesher, Senior Vice President- Global Human Resources
  • Dirk Hondmann Ph.D., Chief Scientific Officer
  • James M. Cornelius, Non-Executive Chairman of the Board
  • Elliot Sigal M.D. Ph.D., Director

Who owns Mead Johnson Nutrition CO stock?

Mead Johnson Nutrition CO's stock is owned by a variety of of institutional and retail investors. Top institutional investors include First National Bank of Omaha (0.00%). Company insiders that own Mead Johnson Nutrition CO stock include Anna C Catalano, Christoper Richard Stratton, Graciela Monteagudo, Howard B Bernick, James M Cornelius, Kimberly A Casiano, Michel Martinus Gerardus Cup and Robert S Singer. View Institutional Ownership Trends for Mead Johnson Nutrition CO.

How do I buy Mead Johnson Nutrition CO stock?

Shares of Mead Johnson Nutrition CO can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mead Johnson Nutrition CO's stock price today?

One share of Mead Johnson Nutrition CO stock can currently be purchased for approximately $89.98.

MarketBeat Community Rating for Mead Johnson Nutrition CO (NYSE MJN)
Community Ranking:  2.2 out of 5 ( )
Outperform Votes:  301 (Vote Outperform)
Underperform Votes:  370 (Vote Underperform)
Total Votes:  671
MarketBeat's community ratings are surveys of what our community members think about Mead Johnson Nutrition CO and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Mead Johnson Nutrition CO (NYSE:MJN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 12 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $84.80 (5.76% downside)

Analysts' Ratings History for Mead Johnson Nutrition CO (NYSE:MJN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/5/2017Canaccord GenuityReiterated RatingSpeculative BuyLowView Rating Details
6/15/2017BMO Capital MarketsReiterated RatingHold$90.00LowView Rating Details
4/3/2017Wells Fargo & CompanyDowngradeOutperform -> Market Perform$89.00LowView Rating Details
4/1/2017Susquehanna Bancshares IncSet Price TargetHold$78.00 -> $90.00LowView Rating Details
3/6/2017Citigroup Inc.DowngradeBuy -> NeutralN/AView Rating Details
3/5/2017Credit Suisse GroupDowngradeOutperform -> Neutral$90.00N/AView Rating Details
2/13/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
2/2/2017Berenberg BankUpgradeSell -> Hold$66.00N/AView Rating Details
10/28/2016Deutsche Bank AGLower Price TargetHold$85.00 -> $78.00N/AView Rating Details
10/28/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$90.00 -> $75.00N/AView Rating Details
9/27/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$96.00 -> $85.00N/AView Rating Details
7/29/2016Societe GeneraleDowngradeBuy -> Hold$100.00 -> $95.00N/AView Rating Details
7/13/2016Bank of America CorporationUpgradeUnderperform -> Neutral$93.00N/AView Rating Details
2/1/2016NomuraBoost Price TargetNeutral$85.00 -> $88.00N/AView Rating Details
(Data available from 7/25/2015 forward)


Earnings History for Mead Johnson Nutrition CO (NYSE:MJN)
Earnings by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)
Earnings History by Quarter for Mead Johnson Nutrition CO (NYSE MJN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2017Q1 17$0.79$0.80$911.63 million$883.50 millionViewN/AView Earnings Details
1/26/2017Q416$0.81$0.78$928.84 million$901.60 millionViewListenView Earnings Details
10/27/2016Q316$0.86$0.87$933.43 million$937.50 millionViewListenView Earnings Details
7/28/2016Q216$0.78$0.88$967.25 million$941.50 millionViewListenView Earnings Details
4/28/2016Q116$0.85$0.87$957.03 million$962.10 millionViewListenView Earnings Details
1/28/2016Q415$0.73$0.78$971.23 million$967.00 millionViewListenView Earnings Details
10/22/2015Q315$0.85$0.80$1.03 billion$977.50 millionViewListenView Earnings Details
7/23/2015Q215$0.77$0.76$1.10 billion$1.03 billionViewListenView Earnings Details
4/23/2015Q115$1.05$1.09$1.13 billion$1.09 billionViewListenView Earnings Details
1/29/2015Q414$0.88$0.92$1.11 billion$1.09 billionViewListenView Earnings Details
10/23/2014Q314$0.91$0.93$1.08 billion$1.09 billionViewListenView Earnings Details
7/22/2014Q214$0.89$0.88$1.10 billion$1.11 billionViewListenView Earnings Details
4/24/2014Q114$0.91$1.02$1.10 billion$1.11 billionViewListenView Earnings Details
1/31/2014Q413$0.77$0.78$1.05 billion$1.06 billionViewListenView Earnings Details
10/24/2013Q313$0.79$0.91$998.04 million$1.05 billionViewListenView Earnings Details
7/25/2013Q2 2013$0.83$0.84$1.04 billion$1.06 billionViewListenView Earnings Details
4/25/2013Q1 2013$0.85$0.85$1.02 billion$1.04 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.68$0.72$953.84 million$981.10 millionViewListenView Earnings Details
10/25/2012$0.72$0.71ViewN/AView Earnings Details
7/26/2012$0.76$0.83ViewN/AView Earnings Details
4/26/2012$0.78$0.82ViewN/AView Earnings Details
1/26/2012$0.51$0.52ViewN/AView Earnings Details
10/27/2011$0.77$0.78ViewN/AView Earnings Details
7/28/2011$0.69$0.72ViewN/AView Earnings Details
4/28/2011$0.72$0.76ViewN/AView Earnings Details
1/27/2011$0.56$0.57ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Mead Johnson Nutrition CO (NYSE:MJN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171$0.74$0.74$0.74
Q3 20171$0.83$0.83$0.83
Q4 20171$0.83$0.83$0.83
(Data provided by Zacks Investment Research)


Current Dividend Information for Mead Johnson Nutrition CO (NYSE:MJN)
Most Recent Dividend:7/5/2017
Annual Dividend:$1.65
Dividend Yield:1.83%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:51.72% (Trailing 12 Months of Earnings)
50.00% (Based on This Year's Estimates)
47.97% (Based on Next Year's Estimates)
Track Record:7 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)

Dividend History by Quarter for Mead Johnson Nutrition CO (NYSE MJN)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Mead Johnson Nutrition CO (NYSE:MJN)
Insider Ownership Percentage: 0.50%
Institutional Ownership Percentage: 88.40%
Insider Trades by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)
Institutional Ownership by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)
Insider Trades by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/31/2016Anna C CatalanoDirectorSell656$74.99$49,193.44View SEC Filing  
8/15/2016Kimberly A CasianoDirectorSell710$89.75$63,722.50View SEC Filing  
8/5/2016Graciela MonteagudoSVPSell45,873$87.64$4,020,309.72View SEC Filing  
5/2/2016Christoper Richard StrattonSVPSell33,730$86.66$2,923,041.80View SEC Filing  
12/14/2015Michel Martinus Gerardus CupCFOBuy4,000$76.50$306,000.00View SEC Filing  
11/25/2015Robert S SingerDirectorSell4,000$81.77$327,080.00View SEC Filing  
9/2/2015Anna C CatalanoDirectorSell1,125$76.60$86,175.00View SEC Filing  
9/1/2015Kimberly A CasianoDirectorSell1,138$76.61$87,182.18View SEC Filing  
8/24/2015James M CorneliusDirectorBuy10,000$77.10$771,000.00View SEC Filing  
8/20/2015Howard B. BernickDirectorBuy5,000$79.95$399,750.00View SEC Filing  
7/27/2015James M CorneliusDirectorBuy10,000$89.03$890,300.00View SEC Filing  
5/13/2015Weerdt Tom DeVPSell7,585$95.64$725,429.40View SEC Filing  
5/8/2015Robert S SingerDirectorSell5,000$95.81$479,050.00View SEC Filing  
5/1/2015Charles M UrbainSVPSell5,000$95.89$479,450.00View SEC Filing  
4/30/2015Howard B BernickDirectorBuy4,000$96.33$385,320.00View SEC Filing  
4/15/2015Stephen W GolsbyDirectorSell5,000$101.31$506,550.00View SEC Filing  
3/16/2015Stephen W GolsbyDirectorSell5,000$100.00$500,000.00View SEC Filing  
2/17/2015Stephen W GolsbyDirectorSell5,000$101.39$506,950.00View SEC Filing  
2/3/2015James M CorneliusDirectorBuy10,000$99.78$997,800.00View SEC Filing  
2/2/2015Charles M UrbainSVPSell5,000$98.34$491,700.00View SEC Filing  
1/15/2015Stephen W GolsbyDirectorSell5,000$99.11$495,550.00View SEC Filing  
12/24/2014William P'poolVPSell21,375$101.22$2,163,577.50View SEC Filing  
12/15/2014Stephen W GolsbyDirectorSell5,000$96.83$484,150.00View SEC Filing  
11/17/2014Stephen W GolsbyDirectorSell178,783$99.56$17,799,635.48View SEC Filing  
11/17/2014William P'poolVPSell19,879$99.99$1,987,701.21View SEC Filing  
11/14/2014Stephen W GolsbyDirectorSell5,000$99.20$496,000.00View SEC Filing  
11/3/2014Robert S SingerDirectorSell6,000$100.56$603,360.00View SEC Filing  
10/27/2014James J JobeSVPSell13,956$101.90$1,422,116.40View SEC Filing  
10/15/2014Stephen W GolsbyDirectorSell10,000$91.33$913,300.00View SEC Filing  
9/15/2014Stephen W GolsbyDirectorSell10,000$96.43$964,300.00View SEC Filing  
8/15/2014Stephen W GolsbyDirectorSell10,000$95.11$951,100.00View SEC Filing  
8/8/2014Peter G LeemputteCFOSell76,212$91.56$6,977,970.72View SEC Filing  
7/22/2014Dirk HondmannSVPSell15,668$97.00$1,519,796.00View SEC Filing  
7/15/2014Stephen W GolsbyDirectorSell10,000$93.83$938,300.00View SEC Filing  
6/18/2014Charles M UrbainSVPSell23,502$90.00$2,115,180.00View SEC Filing  
6/18/2014William P'poolVPSell5,659$90.00$509,310.00View SEC Filing  
6/16/2014Stephen W GolsbyDirectorSell10,000$87.42$874,200.00View SEC Filing  
5/30/2014Robert S SingerDirectorSell3,000$89.27$267,810.00View SEC Filing  
5/29/2014Dirk HondmannSVPSell14,559$87.83$1,278,716.97View SEC Filing  
5/29/2014Robert S SingerDirectorSell3,000$87.40$262,200.00View SEC Filing  
5/15/2014Stephen GolsbyDirectorSell10,000$85.76$857,600.00View SEC Filing  
5/14/2014Dirk HondmannSVPSell1,503$87.83$132,008.49View SEC Filing  
5/12/2014Dirk HondmannSVPSell6,355$87.00$552,885.00View SEC Filing  
4/15/2014Stephen GolsbyDirectorSell10,000$83.25$832,500.00View SEC Filing  
4/1/2014Charles UrbainSVPSell11,298$85.00$960,330.00View SEC Filing  
4/1/2014William P'poolVPSell8,405$85.00$714,425.00View SEC Filing  
3/14/2014Stephen GolsbyDirectorSell10,000$82.44$824,400.00View SEC Filing  
3/4/2014Stephen GolsbyDirectorSell104,452$83.41$8,712,341.32View SEC Filing  
2/21/2014Peter LeemputteCFOSell30,704$80.59$2,474,435.36View SEC Filing  
2/14/2014Stephen GolsbyDirectorSell10,000$77.78$777,800.00View SEC Filing  
1/15/2014Stephen GolsbyDirectorSell10,000$83.12$831,200.00View SEC Filing  
12/16/2013Stephen GolsbyDirectorSell10,000$82.68$826,800.00View SEC Filing  
11/15/2013Stephen GolsbyDirectorSell10,000$84.08$840,800.00View SEC Filing  
10/15/2013Stephen GolsbyDirectorSell10,000$75.28$752,800.00View SEC Filing  
9/16/2013Stephen GolsbyDirectorSell10,000$77.22$772,200.00View SEC Filing  
8/15/2013James CorneliusDirectorBuy10,000$75.99$759,900.00View SEC Filing  
7/15/2013Stephen W GolsbyDirectorSell10,000$74.15$741,500.00View SEC Filing  
6/14/2013Stephen W GolsbyDirectorSell10,000$82.09$820,900.00View SEC Filing  
5/15/2013Stephen W GolsbyDirectorSell10,000$79.97$799,700.00View SEC Filing  
4/30/2013Howard B BernickDirectorBuy3,511$82.38$289,236.18View SEC Filing  
11/15/2012Stephen W GolsbyCEOSell10,000$66.87$668,700.00View SEC Filing  
11/1/2012Peter G LeemputteCFOBuy3,000$63.61$190,830.00View SEC Filing  
10/31/2012James M CorneliusDirectorBuy10,000$61.75$617,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Mead Johnson Nutrition CO (NYSE:MJN)
Latest Headlines for Mead Johnson Nutrition CO (NYSE:MJN)
DateHeadline logo[$$] Reckitt chief tries to find formula for Mead Johnson growth - July 25 at 12:11 AM logoMcCormick to Buy Reckitt Food Unit for $4 Billion, FT Says - July 18 at 11:30 PM logoMn Services Vermogensbeheer BV Buys Apple Inc, Microsoft Corp, Amazon. ... - Nasdaq - July 16 at 12:56 PM logoMead Johnson Nutrition Company (NYSE:MJN) Earns "Speculative Buy" Rating from Canaccord Genuity - July 5 at 4:26 PM logoMead Johnson Nutrition Company (MJN) Receives Consensus Rating of "Hold" from Brokerages - July 3 at 8:44 PM logoMead Johnson Nutrition Company (MJN) Sees Large Drop in Short Interest - July 3 at 7:04 AM logoBMO Capital Markets Reiterates Hold Rating for Mead Johnson Nutrition Company (MJN) - June 18 at 12:52 AM logoMead Johnson Nutrition Merger with Reckitt Benckiser Completed - June 16 at 7:46 AM logoMead Johnson Nutrition Company (MJN) Stock Rating Upgraded by BidaskClub - June 14 at 7:20 PM logoReckitt Benckiser Treasury Services Plc -- Moody's downgrades Reckitt Benckiser's ratings to A3 and P-2; stable outlook - June 13 at 6:41 PM logoFinal Approval Received For Acquisition Of Mead Johnson By Reckitt Benckiser - Nasdaq - June 13 at 5:52 AM logoReckitt to Close $18 Billion Mead Johnson Takeover - Investopedia - June 13 at 5:52 AM logoReckitt to Close $18 Billion Mead Johnson Takeover - June 13 at 5:52 AM logoBRIEF-Mead Johnson receives final approval for acquisition of co by Reckitt Benckiser - June 12 at 3:55 PM logoFinal Approval Received for Acquisition of Mead Johnson by Reckitt Benckiser - June 12 at 3:55 PM logoMead Johnson Nutrition CO Target of Unusually Large Options Trading (MJN) - June 7 at 9:02 AM logoMead Johnson Nutrition CO (MJN) Given Consensus Recommendation of "Hold" by Brokerages - June 6 at 8:32 PM logoMead Johnson Stockholders Approve Acquisition by RB; Mead Johnson Nutrition Board Announces Dividend - Business Wire (press release) - June 2 at 5:28 AM logoMead Johnson (MJN) Stockholders Approve Acquisition by Reckitt Benckiser - May 31 at 11:55 PM logoBRIEF-Mead Johnson stockholders approve acquisition by RB - May 31 at 11:55 PM logoMead Johnson Nutrition CO to Issue Quarterly Dividend of $0.41 (MJN) - May 31 at 6:54 PM logoMead Johnson Stockholders Approve Acquisition by RB; Mead Johnson Nutrition Board Announces Dividend - May 31 at 6:54 PM logo$907.03 Million in Sales Expected for Mead Johnson Nutrition CO (MJN) This Quarter - May 31 at 1:05 PM logoMead Johnson Nutrition CO (MJN) Expected to Announce Earnings of $0.75 Per Share - May 29 at 4:16 PM logoPaul Singer Gains 9 New Holdings in 1st Quarter - Nasdaq - May 26 at 7:23 PM logoETFs with exposure to Mead Johnson Nutrition Co. : May 22, 2017 - May 22 at 5:53 PM logoMead Johnson Nutrition CO (MJN) Given Average Recommendation of "Hold" by Brokerages - May 12 at 8:50 PM logoMead Johnson Nutrition CO (MJN) Expected to Post Quarterly Sales of $907.03 Million - May 6 at 10:34 AM logoMead Johnson Nutrition CO (MJN) Getting Somewhat Favorable News Coverage, AlphaOne Reports - May 5 at 11:45 PM logoMead Johnson Nutrition CO (MJN) Expected to Post Earnings of $0.75 Per Share - May 4 at 10:02 AM logoETFs with exposure to Mead Johnson Nutrition Co. : May 2, 2017 - May 2 at 8:05 PM logoMead Johnson Nutrition Co. :MJN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 - May 1 at 12:35 PM logoMead Johnson Nutrition CO (MJN) Lowered to Sell at Zacks Investment Research - April 29 at 2:03 PM logoMead Johnson Nutrition CO (MJN) Announces Earnings Results, Beats Estimates By $0.01 EPS - April 29 at 1:27 AM logoMead Johnson Nutrition Reports First Quarter 2017 Results - Business Wire (press release) - April 29 at 12:30 AM logoMead Johnson Nutrition CO (MJN) Receives Daily News Sentiment Score of -0.03 - April 28 at 3:06 PM logoRisk Arbitrage Today: Dutch Auction In CIT Group - April 28 at 9:19 AM logoMead Johnson misses Street 1Q forecasts - April 27 at 7:05 PM logoMead Johnson (MJN) Misses Q1 Earnings and Sales Estimates - April 27 at 7:05 PM logoMead Johnson Nutrition: 2017 Earnings Guidance No Longer Applicable - April 27 at 9:39 AM logoBRIEF-Mead Johnson nutrition Q1 non-GAAP earnings per share $0.80 excluding items - April 27 at 9:39 AM logoMead Johnson Nutrition Co. Announces 65% Increase In Q1 Bottom Line - April 27 at 9:39 AM logoMead Johnson Nutrition Reports First Quarter 2017 Results - April 27 at 9:39 AM logoYieldBoost Mead Johnson Nutrition From 1.9% To 2.1% Using Options - April 25 at 5:53 PM logoMead Johnson Nutrition CO (MJN) Earns Daily News Sentiment Score of 0.15 - April 24 at 9:32 PM logoMead Johnson Nutrition CO (MJN) Earning Somewhat Favorable Press Coverage, Analysis Finds - April 21 at 6:59 PM logoMead Johnson Nutrition CO (MJN) Earns Daily Media Sentiment Rating of 0.08 - April 18 at 12:35 AM logoMead Johnson Nutrition CO (MJN) Receives Consensus Recommendation of "Hold" from Brokerages - April 17 at 8:39 PM logoDavid Rolfe Comments on Mead Johnson - April 15 at 9:16 AM logoMead Johnson Nutrition CO (MJN) Earns Daily Media Sentiment Rating of 0.14 - April 14 at 10:49 PM



Mead Johnson Nutrition CO (MJN) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by Staff